Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Tafazzin (TAZ) (Middle Region) Peptide

TAZ Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5511601
  • Antigène Tous les produits TAZ
    TAZ (Tafazzin (TAZ))
    Protein Region
    Middle Region
    Origine
    Humain
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Séquence
    LHSHFFSLGK CVPVCRGAEF FQAENEGKGV LDTGRHMPGA GKRREKGDGV
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-TAZ Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    TAZ (Tafazzin (TAZ))
    Synonymes
    wu:fb39f12 Peptide, zgc:91803 Peptide, MGC54019 Peptide, TAZ Peptide, taz Peptide, GB11956 Peptide, Afu2g13960 Peptide, BTHS Peptide, CMD3A Peptide, EFE Peptide, EFE2 Peptide, G4.5 Peptide, LVNCX Peptide, Taz1 Peptide, 5031411C02Rik Peptide, 9130012G04Rik Peptide, AW107266 Peptide, AW552613 Peptide, tafazzin Peptide, tafazzin L homeolog Peptide, tafazzin homolog Peptide, TAZ Peptide, taz Peptide, taz.L Peptide, LOC550948 Peptide, AFUA_2G13960 Peptide, AOR_1_318014 Peptide, Tsp_06712 Peptide, Taz Peptide
    Sujet
    This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.

    Alias Symbols: TAZ,EFE2,G4.5,

    Protein Size: 292
    ID gène
    6901
    UniProt
    Q16635
Vous êtes ici:
Support technique